News Releases

News Releases

Share
Share
and/or
400 News Releases found
Luis Alberto Diaz, Jr., MD and Andrea Cercek, MD
ASCO 2022: 100% Complete Response Rate in MMRd Locally Advanced Rectal Cancer Seen in Pivotal ‘Immunoablative’ Neoadjuvant Immunotherapy Clinical Trial
Breakthrough findings were presented at the 2022 ASCO Annual Meeting and published in The New England Journal of Medicine today by researchers at Memorial Sloan Kettering Cancer Center (MSK) confirming a clinical complete response in all 14 patients who received the immunotherapy treatment dostarlimab as a first-line treatment for mismatch repair-deficient (MMRd) locally advanced rectal cancer. This new approach of “immunoablative” therapy uses immunotherapy to replace surgery, chemotherapy and radiation to remove cancer.
Shanu Modi
ASCO 2022: Practice-Changing Findings Identify HER2-Low as a Targetable Subset of Breast Cancer, Redefining Treatment for More Than 60 Percent of HER2-Negative Metastatic Breast Cancer Patients
New data from researchers at MSK featured in the 2022 ASCO Annual Meeting press program and simultaneously published in The New England Journal of Medicine highlights a novel antibody-drug conjugate that doubled progression-free survival in HER2-low metastatic breast cancer.
Cancer Care Closer to Home: Physicians of Memorial Sloan Kettering Cancer Center and New York Cancer & Blood Specialists to Open New Cancer Care Facility in Brooklyn
Memorial Sloan Kettering Cancer Center (MSK) and New York Cancer & Blood Specialists (NYCBS), one of the fastest-growing community oncology practices in the nation, today announced plans to open a 39,000 sq ft facility in Brooklyn, New York, in early 2023.
Shanu Modi, MD, Andrea Cercek, MD, Vinod Balachandran, MD, and Jonathan Yang, MD, PhD
ASCO 2022: Memorial Sloan Kettering Cancer Center Experts To Present Significant Research at the American Society of Clinical Oncology Annual Meeting
Physicians and scientists from MSK will join oncology experts and members of the global cancer research community to present the latest advances in cancer during the 2022 ASCO Annual Meeting, June 3–7 in Chicago.
MSK Awards & Appointments May 2022
Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments:
Memorial Sloan Kettering Cancer Center Study Points to Expanded Genomic Testing that Aims To Benefit Children and Young Adults With Cancer
By sequencing the entire genome of a tumor, the experimental test will go beyond standard testing for common cancers in adults.
2022 Robbins Family Award for Nursing Excellence Winners
Celebrating Exceptional Service in Nursing at Memorial Sloan Kettering Cancer Center: Third Annual Robbins Family Awards
Memorial Sloan Kettering Cancer Center (MSK) and the Robbins Family Foundation are proud to announce today that 13 distinguished MSK nurses and one nursing team were recognized with the 2022 Robbins Family Award for Nursing Excellence. During National Nurses Week (May 6 – 12), MSK recognizes outstanding nurses for exemplary service.
The MSK Ralph Lauren Center
Ralph Lauren Corporate Foundation Announces $25 Million Commitment to Five Cancer Centers Across America With Goal of Reducing Disparities in Cancer Care in Underserved Communities 
The Ralph Lauren Corporate Foundation announced today that it's providing $25 million in new grant funding to expand or establish five Ralph Lauren cancer centers, aimed at reducing disparities in cancer care and access across underserved communities. The funding will benefit institutions including the Memorial Sloan Kettering (MSK) Ralph Lauren Center in Harlem.
Cycle for Survival
Cycle for Survival Makes History by Surpassing $300 Million for Rare Cancer Research
The Cycle for Survival community, along with founding partner, Equinox, achieves a historic fundraising milestone, fueling rare cancer research at Memorial Sloan Kettering.
MSK Awards & Appointments April 2022
Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments: